Peihao Wen

1.1k total citations
39 papers, 749 citations indexed

About

Peihao Wen is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Peihao Wen has authored 39 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Surgery and 10 papers in Cancer Research. Recurrent topics in Peihao Wen's work include Organ Transplantation Techniques and Outcomes (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Peihao Wen is often cited by papers focused on Organ Transplantation Techniques and Outcomes (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Peihao Wen collaborates with scholars based in China, United Kingdom and Germany. Peihao Wen's co-authors include Wenzhi Guo, Shuijun Zhang, Jiakai Zhang, Xiaoyi Shi, Zhihui Wang, Jihua Shi, Qiang He, Yu Liu, Shengli Cao and Hongwei Tang and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Peihao Wen

35 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peihao Wen China 14 447 261 131 87 79 39 749
Chengyong Tang China 12 319 0.7× 209 0.8× 140 1.1× 109 1.3× 84 1.1× 21 695
Shuqiang Yue China 16 465 1.0× 265 1.0× 64 0.5× 82 0.9× 113 1.4× 28 802
Pengcheng Luo China 17 377 0.8× 183 0.7× 206 1.6× 37 0.4× 85 1.1× 26 775
Lihuan Guan China 16 315 0.7× 157 0.6× 87 0.7× 55 0.6× 58 0.7× 27 664
Minglu Liang China 20 441 1.0× 185 0.7× 128 1.0× 31 0.4× 98 1.2× 52 884
Huilai Miao China 16 428 1.0× 180 0.7× 127 1.0× 45 0.5× 73 0.9× 36 771
Marta Anna Kowalik Italy 20 749 1.7× 318 1.2× 330 2.5× 167 1.9× 111 1.4× 40 1.4k
Tomoki Yagai United States 15 340 0.8× 106 0.4× 225 1.7× 105 1.2× 85 1.1× 19 734
Praveen Kusumanchi United States 16 384 0.9× 202 0.8× 280 2.1× 86 1.0× 66 0.8× 34 822
Lu Gao China 16 363 0.8× 192 0.7× 72 0.5× 32 0.4× 45 0.6× 32 758

Countries citing papers authored by Peihao Wen

Since Specialization
Citations

This map shows the geographic impact of Peihao Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peihao Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peihao Wen more than expected).

Fields of papers citing papers by Peihao Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peihao Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peihao Wen. The network helps show where Peihao Wen may publish in the future.

Co-authorship network of co-authors of Peihao Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Peihao Wen. A scholar is included among the top collaborators of Peihao Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peihao Wen. Peihao Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jingjie, Yiran Xu, Jiajia Chen, et al.. (2025). Early bacterial pathogen distribution and risk factors for infections after liver transplantation: Retrospective cohort study. International Journal of Infectious Diseases. 156. 107907–107907. 1 indexed citations
2.
Zhao, An, Changjun Huang, Minghao Li, et al.. (2025). EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Progression. Annals of Surgical Oncology. 33(3). 2169–2188.
3.
Chen, Yabin, Peihao Wen, Jiakai Zhang, et al.. (2025). Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia. Journal of Zhejiang University SCIENCE B. 26(5). 461–476.
4.
Zhang, Huapeng, Jie Yu, Feng Zhang, et al.. (2025). BRD4 interacting genes as prognostic biomarkers in hepatocellular carcinoma for optimized treatment strategies. Scientific Reports. 15(1). 5617–5617.
5.
Liu, Yuan, Jinxin Zheng, Peihao Wen, et al.. (2024). Impact of varied immunosuppressive agents and post-transplant diabetes mellitus on prognosis among diverse transplant recipients (experimental studies). International Journal of Surgery. 110(4). 2007–2024. 3 indexed citations
6.
7.
Gao, Jie, et al.. (2023). m6A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6A‐EGFR/STAT3 axis and EMT. Molecular Carcinogenesis. 62(10). 1599–1614. 13 indexed citations
8.
Hu, Bowen, Jie Gao, Jihua Shi, et al.. (2022). Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma. Frontiers in Immunology. 13. 970117–970117. 6 indexed citations
9.
Zhang, Pengfei, et al.. (2021). circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma. Molecular Therapy — Nucleic Acids. 27. 293–303. 35 indexed citations
10.
Du, Yabing, Wang Ma, Peihao Wen, et al.. (2021). Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1. Pharmacological Research. 169. 105648–105648. 31 indexed citations
11.
Wu, Yi, Fang Fang, Zhaowen Wang, Peihao Wen, & Junwei Fan. (2021). The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose–corrected trough concentration in the early period after liver transplantation. European Journal of Clinical Pharmacology. 77(6). 859–867. 5 indexed citations
12.
Liu, Weifeng, Dongjing Yang, Jihua Shi, et al.. (2021). Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney. Frontiers in Surgery. 8. 760989–760989. 6 indexed citations
13.
Gao, Jie, Huapeng Zhang, Yaohui Sun, et al.. (2020). Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation. Cancer Letters. 482. 8–18. 13 indexed citations
14.
Chen, Sanyang, Jie Li, Jihua Shi, et al.. (2020). Donor Brain Death Leads to a Worse Ischemia-Reperfusion Injury and Biliary Injury After Liver Transplantation in Rats. Transplantation Proceedings. 52(1). 373–382. 4 indexed citations
15.
Li, Jiye, Dongsheng Yu, Sanyang Chen, et al.. (2020). Sirt6 opposes glycochenodeoxycholate-induced apoptosis of biliary epithelial cells through the AMPK/PGC-1α pathway. Cell & Bioscience. 10(1). 43–43. 19 indexed citations
16.
Chen, Tianran, Xiao‐Qing Guan, Fangjun Wang, et al.. (2019). Biflavones from Ginkgo biloba as inhibitors of human thrombin. Bioorganic Chemistry. 92. 103199–103199. 64 indexed citations
17.
Wang, Yan, Weijia Li, Xiangyu Chen, et al.. (2019). MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 111. 1297–1301. 52 indexed citations
18.
Zhang, Tao, Yuan Liu, Rong Zeng, et al.. (2017). Association of donor small ubiquitin‐like modifier 4 rs237025 genetic variant with tacrolimus elimination in the early period after liver transplantation. Liver International. 38(4). 724–732. 11 indexed citations
19.
Wang, Shuyun, Peihao Wen, Shuang Liu, et al.. (2013). A novel model for orthotopic liver transplantation in rats using hepatic rearterialization and biliary extradrainage system. Journal of Surgical Research. 187(2). 690–698. 4 indexed citations
20.
Wen, Peihao, Xiaogang Wang, Tao Li, et al.. (2013). Establishment of a novel volume-loaded heterotopic heart transplantation model in rats. Journal of Surgical Research. 183(1). 435–441. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengyong Tang Breakdown of academic impact, for papers by Shuqiang Yue Breakdown of academic impact, for papers by Pengcheng Luo Breakdown of academic impact, for papers by Lihuan Guan Breakdown of academic impact, for papers by Minglu Liang Breakdown of academic impact, for papers by Huilai Miao Breakdown of academic impact, for papers by Marta Anna Kowalik Breakdown of academic impact, for papers by Tomoki Yagai Breakdown of academic impact, for papers by Praveen Kusumanchi Breakdown of academic impact, for papers by Lu Gao
Rankless by CCL
2026